Wed, March 5, 2025

by: Mint

How India's youngest pension fund gamed a falling market to outdo its older rivals

DSP's NPS Equity Fund has delivered 11.68% return in the last one year, five times more than Kotak Mahindra Pension Fund. How did the new kid on the block beat rivals? CIO Ramneek Kundra weighs in

by: WOPRAI

120 Earnings Releases for Mar 05th, 2025

by: cnbctv18

Apollo Hospitals to invest ?250 crore in India's first Proteus One proton therapy system

The new facility will be located in Hyderabad and is expected to be operational by FY2028. Proton therapy is used for complex cancers, including central nervous system, head and neck tumours, paediatric,
Tue, March 4, 2025

by: Reuters

Europe's Defence Stocks Extend Rally as Trump Pauses Military Aid to Ukraine

An index of aerospace and defence companies was up 0.8% to new record high at 1224 GMT, an outlier in a sea of red, with region-wide STOXX 600 dropping 1.4%, as U.S. tariffs on Canada, Mexico and China took effect.

by: Reuters

Investors say it's time to take Trump seriously as markets recoil on wall of tariffs

Markets no longer think Donald Trump is full of bluster and are moving quickly to anticipate a slowdown in U.S. and global growth as he raises a wall of tariffs around the world's biggest economy and trading partners start to respond in kind.

by: Crypto

Dave Ramsey warns on crypto, stick to 401(k)s and Roth IRA

Financial guru Dave Ramsey isn't buying the crypto hype. In a blog post in September, he likened crypto investing to gambling, warning that it's too unpredictable to build long-term wealth. "At this point,

by: Forbes

Financial Literacy Lessons From 5 Past Oscars Movies

This article explores five critically acclaimed films from past Oscars that not only captivated audiences but serve as a masterclass in financial literacy.

by: bnnbloomberg

JPMorgan traders turn glum on U.S. stocks, expecting tariff pain

As President Donald Trump unleashes a salvo of tariffs on nations around the globe, the trading desk at JPMorgan Chase & Co. is bracing for US equities to extend losses as levies weigh on growth at home and overseas.

by: MarketWatch

What 125 years of data says about diversification and investing at record highs

Making its way around social media was the clip from "Ferris Bueller's Day Off" in which the economist Ben Stein explained the Smoot-Hawley Act, when Republicans raised tariffs in a bid to increase revenue and ended up exacerbating the Great Depression. Wonder if there's any current relevance.

by: MSN

I'd invest $20k in ASX dividend shares now to make a passive income

Generating meaningful passive income is possible with ASX shares. Here's how I would do it. The post I'd invest $20k in ASX dividend shares now to make a passive income appeared first on The Motley Fool Australia.

by: AOL

If you'd invested $1,000 at Microsoft's IPO, here's how much you'd have now

If you'd been around when Microsoft went public in March of 1986, you would have been wise to buy the stock. A $1,000 investment in Microsoft at its IPO is now worth an astounding sum.

by: MSN

Top 100 Stocks to Buy: Coastal Financial Jumps Into the Top 20. Time to Buy?

Barchart's Top 100 Stocks to Buy often include high-growth, money-losing businesses. Investors continue to look for the big score despite the economic black clouds. On Monday, Coastal Financial (CCB),

by: Investing

US stocks slump, continuing the tariff-driven selloff

The prospect of a worsening trade war between China and the U.S., the world's biggest economies, has also helped traders largely look past signs of a potential escalation in the Russia-Ukraine war, after the U.S. halted all military aid to Ukraine.

by: Reuters

Stocks drop as Trump says tariffs start Tuesday; euro gains

NEW YORK (Reuters) -U.S. stocks ended down sharply Monday, with the S&P 500 posting its biggest daily percentage drop since December 18 after U.S. President Donald Trump said 25% tariffs on Canada and Mexico will go into effect on Tuesday, while the euro strengthened after European leaders agreed to draw up a Ukraine peace plan.

by: MSN

What Drives Nvidia's Growth?

An inference compute would be, here are NVIDIA's earnings, and I want you to summarize it and debate the bull and bear cases. You're asking for a larger logic chain. Those are the two forces. The cost is going down,

by: Forbes

Experts Explain How To Invest In Stocks With 11 Simple Tips

Intimidated by the stock market? Here's the solution: 11 expert-provided tips that explain how to invest safely and profitably.

by: MSN

Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price,

by: MSN

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

As the Q4 earnings season wraps, let's dig into this quarter's best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers. Over the next few years,

by: GOBankingRates

2 Reasons Meta Stock Broke Its Winning Streak: Should You Still Invest?

Meta Platforms, formerly known as Facebook, has been a volatile stock over the years, and it still sports a beta of 1.20, according to Yahoo Finance. This means that on average, the stock is 20%

by: MSN

Cash ISAs won't be axed but saving limits may be reduced, minister hints

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and content measurement, audience insights and product development. List of Partners (vendors)

by: GOBankingRates

4 Stocks That Soared During Biden's Presidency

You can argue how much influence and control over the stock market a president has, but the numbers are the numbers. The market's performance reflects, to a degree, how the country or at

by: MSN

Worried About the Market? Here's How Warren Buffett, Ray Dalio, and Harvard University Protect Their Portfolios

Americans are worried about the economy. You might be worried too — but you don't have to worry about your own micro-economy. Just take the reins of your investment portfolio. Here are three asset allocation recipes,

by: Investing

Asia stocks drop tracking Wall Street's plunge after Trump's tariff decision

Investing.com-- Asian stock fell on Tuesday mirroring an overnight slump on Wall Street, after U.S. President Donald Trump confirmed that 25% tariffs on Mexico and Canada were set to take effect later in the day, and signed an order to increase levies on Chinese goods.

by: MSN

Morgan Stanley Raises Nvidia (NVDA) Price Target: Is the Stock Positioned for Further Growth?

We recently published a list of 10 AI Stocks Poised for Big Moves. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other AI stocks poised for big moves.

by: MSN

Is the S&P 500 Ready to Rally? A $1.8M Bet on SPY Says Yes

When investors notice unusual trading activity in any stock, they usually pay dividends to watch out for the reasoning behind the buying activity so that they can also get behind whatever fundamental factor is acting as a tailwind for the underlying company.

by: MSN

3 Dividend Stock ETFs to Buy With $2,000 and Hold Forever

There is no shortage of excellent, low-cost exchange-traded funds (ETFs) that specialize in dividend stocks. There are some that focus on stocks that pay above-average dividends, stocks whose dividends grow rapidly,

by: AOL

Better Artificial Intelligence (AI) Stock: Broadcom vs. Nvidia Stock

Two of the biggest names in artificial intelligence (AI) investing are Nvidia (NASDAQ: NVDA) and Broadcom (NASDAQ: AVGO). Both companies' businesses benefit significantly from the AI arms race, which is why investors are so interested in them.

by: MSN

Elastic N.V. (ESTC): Surpassing Expectations with GenAI and Cloud Solutions

We recently published a list of 10 AI Stocks Poised for Big Moves. In this article, we are going to take a look at where Elastic N.V. (NYSE:ESTC) stands against other AI stocks poised for big moves. Last month,

by: MSN

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

As the Q4 earnings season comes to a close, it's time to take stock of this quarter's best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQ:CORT) and its peers.

by: ThePrint

PrimeAurora Review 2025: Legit Or Scam Trading Platform? - Unveiling Facts!

According to the developers of PrimeAurora, this software provides extensive support to traders in making considered decisions and executing orders accordingly.

by: Forbes

How To Get Rich With These Money Secrets

The difference between those who are struggling financially and those who have figured out how to get rich isn't luck or privilege; it's about financial literacy.

by: Reuters

Analysis-Investors Say It's Time to Take Trump Seriously as Markets Recoil

SINGAPORE (Reuters) - Markets no longer think Donald Trump is full of bluster and are moving quickly to anticipate a slowdown in U.S. and global growth as he raises a wall of tariffs around the world's biggest economy and trading partners start to respond in kind.

by: MSN

Hyperscale Data, Inc. (GPUS) Shifts Focus to AI Data Centers, Reports $150.4M in Pro Forma Revenue for 2024

We recently compiled a list of the 11 AI News and Ratings You Should Take a Look At. In this article, we are going to take a look at where Hyperscale Data, Inc. (NYSEAMERICAN:GPUS) stands against the other AI stocks.

by: Reuters

US Stocks Face Tricky Moment as Trump's Latest Tariffs Loom

While stock valuations have moderated somewhat with the latest pullback, the S&P 500 as of Friday was still trading at 21.7 times based on price-to-earnings estimates, well above its long-term average of 15.8, according to LSEG Datastream.

by: MSN

Why Brainchip, Lottery Corp, Qantas, and Transurban shares are pushing higher

These shares are avoiding the market selloff on Tuesday. Let's find out why. The post Why Brainchip, Lottery Corp, Qantas, and Transurban shares are pushing higher appeared first on The Motley Fool Australia.

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Azitra, Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Immix Biopharma, Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of VS MEDIA Holdings Limited in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Africa Oil Corp. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Intermap Technologies Corporation in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Piedmont Lithium Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Opendoor Technologies Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Gencor Industries, Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Zentalis Pharmaceuticals, Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Auna SA in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Galecto, Inc. in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Actuate Therapeutics, Inc. Common stock in recent trading

by: WOPRAI

As of Mar 04th, 2025, there has been substantial selling of Aptose Biosciences Inc. in recent trading

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

As the Q4 earnings season wraps, let's dig into this quarter's best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers. Over the next few years,

The article from MSN Money discusses the performance and potential of Sarepta Therapeutics (SRPT) and other therapeutics stocks in the fourth quarter. It highlights how Sarepta Therapeutics, a company focused on developing treatments for rare diseases, has shown significant promise with its gene therapy and RNA-based treatments for Duchenne muscular dystrophy. The piece notes that despite the high-risk nature of biotech investments, Sarepta has managed to attract investor interest due to its innovative pipeline and recent FDA approvals. The article also touches on broader market trends, suggesting that therapeutics stocks could be winners in Q4 due to advancements in medical research, regulatory successes, and the ongoing demand for new treatments. It advises investors to look for companies with strong fundamentals, upcoming catalysts like FDA decisions, and robust clinical trial results, positioning Sarepta as a notable example in this sector.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/savingandinvesting/spotting-winners-sarepta-therapeutics-nasdaq-srpt-and-therapeutics-stocks-in-q4/ar-AA1Adomy